Biological Evaluation of <sup>131</sup>I- and CF750-Labeled Dmab(scFv)-Fc Antibodies for Xenograft Imaging of CD25-Positive Tumors

<table>Purification of the Dmab(scFv)-Fc antibody. (a) SDS-PAGE analysis of the Dmab(scFv)-Fc antibody (6 <i>μ</i>g) in the presence (+) or absence (−) of 2-ME. (b) Gel filtration chromatography of the Dmab(scFv)-Fc antibody (360 <i>μ</i>g). The Dmab(scFv) antibody (300 <i>μ</i>g) was used as a control.</table>

BioMed Research International

fig1

Figure 1

Figure 1: Biological Evaluation of <sup>131</sup>I- and CF750-Labeled Dmab(scFv)-Fc Antibodies for Xenograft Imaging of CD25-Positive Tumors 

BioMed Research International

Biological Evaluation of 131I- and CF750-Labeled Dmab(scFv)-Fc Antibodies for Xenograft Imaging of CD25-Positive Tumors

Figure 1

Biological Evaluation of ¹³¹I- and CF750-Labeled Dmab(scFv)-Fc Antibodies for Xenograft Imaging of CD25-Positive Tumors